Alendronic acid in patients with fibrous dysplasia of bone
Phase of Trial: Phase II
Latest Information Update: 14 Nov 2013
Price : $35 *
At a glance
- Drugs Alendronic acid (Primary)
- Indications Metabolic bone diseases
- Focus Therapeutic Use
- 14 Nov 2013 New trial record
- 08 Oct 2013 Results presented at the 35th Annual Meeting of the American Society for Bone and Mineral Research.
- 05 Oct 2013 Primary endpoint 'Osteocalcin-levels' has not been met.